News & Blog

Aspen Neuroscience Announces Pricing of Initial Public Offering

San Diego Union-Tribune: San Diego biotech experiments with treatment for Parkinson’s. Now it’s going public

ProJenX to Present Data Update for the Prosetin Development Program at the 2026 NEALS Annual Meeting

Endpoints News: Aspen and Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Delivering Large Genetic Payloads With SonoThera’s Ken Greenberg

Synaptiq Therapeutics Launches with Acquisition of Clinical-Stage SYN-001 Program

The mega-round mindset: How biotechs are thinking bigger and raising smarter

GenomeWeb: SonoThera Targets 2027 for First Clinical Trial of Duchenne Gene Therapy

Technical.ly: Temple University spinout’s ‘Goldilocks molecules’ could change how we take our medicine